Detalles de la búsqueda
1.
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials.
PLoS Med
; 20(6): e1004176, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279199
2.
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis.
PLoS Med
; 20(1): e1004154, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36649256
3.
Assessing Representativeness of Randomised Controlled Trials using Serious Adverse Events.
Ann Fam Med
; (21 Suppl 1)2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972531
4.
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data.
BMC Med
; 20(1): 410, 2022 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303169
5.
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions.
BMC Med
; 18(1): 309, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087107
6.
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data.
BMJ Med
; 3(1): e000732, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38737200
7.
Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis.
J Multimorb Comorb
; 13: 26335565231213571, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37953975
8.
Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study.
Med Decis Making
; 42(2): 228-240, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407672
9.
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials.
BMJ Med
; 1(1): e000217, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936559
10.
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
BMJ Open
; 12(10): e066491, 2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302574
11.
An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes.
Commun Med (Lond)
; 1: 28, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35602215
12.
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
Lancet Diabetes Endocrinol
; 9(2): 82-93, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357491
13.
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis.
Lancet Healthy Longev
; 1(3): e106-e116, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33313578
14.
Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol.
BMJ Open
; 10(9): e037476, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32873673
Resultados
1 -
14
de 14
1
Próxima >
>>